This opportunity is no longer accepting applications.
grant RFA-DA-25-035

Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance Use and Mental Health Disorders (R01 Clinical Trial Required)

The grant opportunity invites researchers in Substance Use Disorder (SUD) and Mental Health Disorders (MHD) to examine how neuromodulation influences brain circuits and behaviors related to these conditions. Applicants should outline criteria to assess variations in symptoms of SUD and MHD. Studies should include evaluations of how neuromodulation affects specific brain circuits and measure co…

This NOFO seeks applications from the SUD and MHD research communities that coordinate efforts to characterize the effects of neuromodulation on brain circuits and behaviors relevant to both SUD and MHD. To accomplish this goal, studies would specify inclusion/exclusion criteria to capture varia…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: April 15, 2024
Open for Submission: April 15, 2024
Submission Deadline: August 15, 2024
Application Window Closes: August 15, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.